Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALBIREO PHARMA, INC. has filed 1,239 SEC EDGAR filings since 28 Mar 2005

SEC filing history

Showing 726-750 of 938 matching filings.

Per page
25
Current page
30
8-K File 001-33451

8-K

Filing date
18 Dec 2012
Reporting date
18 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Dec 2012
Reporting date
07 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
08 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
07 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
11 Oct 2012
Reporting date
11 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33451

DEF 14A

Filing date
10 Oct 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2012
Reporting date
30 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2012
Reporting date
30 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2012
Reporting date
30 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2012
Reporting date
30 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2012
Reporting date
30 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2012
Reporting date
30 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33451

PRE 14A

Filing date
27 Sep 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33451

CT ORDER filing

Filing date
20 Sep 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-182877

PROSPECTUS

Filing date
14 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-33451

10-Q

Filing date
14 Aug 2012
Reporting date
30 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-182877

EFFECT filing

Filing date
13 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
08 Aug 2012
Reporting date
08 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-182877

FORM S-3

Filing date
27 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83386

SCHEDULE 13G

Filing date
06 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-180500

D filing

Filing date
29 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .